You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Astera Labs expects Scorpio X-Series to exit the year at a well above a billion dollar annualized run rate, up from slightly above zero dollars in Q1, while targeting four or five customers by year-end.
Michael Hurlston resigned from Astera Labs, Inc.’s Board of Directors and its committees effective November 3, 2026. There were no disagreements between Hurlston and the company, and his resignation was unrelated to its operations, policies or practices.
Astera Labs reported third-quarter revenue of $584.9 million, up 154% year over year, driven by higher demand and shipments of Scorpio, Aries and Taurus. Nine-month revenue was $1,285.7 million, up 121%, while gross margin fell to 72.3% from 76.2%.
Astera Labs reported record Q3 2026 revenue of $584.9 million, up 49% sequentially and 154% year-over-year, as Scorpio became its largest product family by revenue. Fourth-quarter revenue is estimated at $730 million to $750 million.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. Q3 delivered record revenue of $584.9 million, $1.32 of non-GAAP diluted EPS, significant operating leverage, accelerated design activity and a record number of product launches, while Scorpio exceeded $1 billion in annualized revenue. Q4 guidance calls for $730 million to $750 million of revenue, approximately 72% non-GAAP gross margin, approximately 45% non-GAAP operating margin and $1.62 to $1.66 of non-GAAP EPS. Risks include year-over-year gross-margin compression, rising operating expenses, constrained supply, customer concentration, changing AI demand, growth-management challenges, absent long-term commitments, product-acceptance risk and tariff or supply-chain exposure.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-GAAP diluted net income per share non-GAAP | $0.8 | Q2 2026 | — |
| Non-GAAP gross margin non-GAAP | 73.7% | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP GAAP gross margin 73.3K
+0.4K Stock-based compensation expense
= Non-GAAP gross margin 73.7K
|
|||
| Non-GAAP gross profit non-GAAP | $289.26M | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP GAAP gross profit 287.57M
+1.69M Stock-based compensation expense
= Non-GAAP gross profit 289.26M
|
|||
| Non-GAAP net income non-GAAP | $145.8M | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP GAAP net income 153.09M
+63.99M Stock-based compensation expense
+232K Acquisition-related costs
-1.5M Other
-70M Income tax effect
= Non-GAAP net income 145.82M
|
|||
| Non-GAAP operating income non-GAAP | $153.5M | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP GAAP operating income 89.25M
+63.99M Stock-based compensation expense
+232K Acquisition-related costs
= Non-GAAP operating income 153.47M
|
|||
| Non-GAAP operating margin non-GAAP | 39.1% | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP GAAP operating margin 22.7K
+16.3K Stock-based compensation expense
+0.1K Acquisition-related costs
= Non-GAAP operating margin 39.1K
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALAB
this stock
Astera Labs, Inc.
|
$38.77B | +33.3% | +115.1% | 88.4 | 4.6% |
|
NVDA
Nvidia Corp
|
$3.92T | -12.7% | +65.5% | 20.6 | 1.2% |
|
TSM
Taiwan Semiconductor Manufacturing Co Ltd
|
$2.07T | +31.2% | — | — | 0.6% |
|
AVGO
Broadcom Inc.
|
$1.66T | +0.3% | +18.2% | 44.3 | 1.1% |
|
SKHY
SK hynix Inc.
|
$929.35B | — | — | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Astera Labs expects Scorpio X-Series to exit the year at a well above a billion dollar annualized run rate, up from slightly above zero dollars in Q1, while targeting four or five customers by year-end.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALAB | +16.3% | -22.4% | -30.4% | -14.3% | +33.3% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | +13.7% | -21.2% | -30.9% | -14.1% | +22.7% |
